Achelios Therapeutics

Achelios Therapeutics is a privately held specialty biopharmaceutical development company with core expertise in reformulating non-steroidal anti-inflammatory drug (NSAID) molecules historically used to treat pain and inflammation. Achelios Therapeutics is building a robust portfolio of drug development assets, including patented pharmaceuticals, compositions, and methods of use. We pursue a strategy of developing compounds with the goal of out-licensing them to potential partners. Achelios Therapeutics is backed by a management team and board with extensive business experience.